Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 -0.53 (-1.65%)
At close: Oct 2, 2026 · 4:00 PM EDT

Celldex Therapeutics (CLDX) Change in Accured Expenses (2010 - 2026)

Updated

Celldex Therapeutics' Change in Accured Expenses came in at $10.14 million for Q2 2026, up 386.0% from $2.09 million a year earlier.

Analysis

Celldex Therapeutics (CLDX) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Change in Accured Expenses of $27.51 million, up 241.0% year-over-year; for FY2025, it came in at $11.03 million, down 5.2% from FY2024.

  • Change in Accured Expenses carries a five-year compound annual growth rate of 46.4% (FY2020 to FY2025).
  • Going back by year, Change in Accured Expenses was $11.63 million in FY2024 (+24.0%), $9.38 million in FY2023 (+200.5%), $3.12 million in FY2022 (-14.5%) and $3.65 million in FY2021 (+123.0%).
  • The five-year range for quarterly Change in Accured Expenses is -$8.72 million (Q1 2025) to $13.06 million (Q3 2025).
  • Year-over-year, Change in Accured Expenses increased in four of the last six quarters, with growth averaging 90.9%.
  • The fastest year-over-year change in Change in Accured Expenses over five years came in Q3 2023 (growth of 435.8%), and the weakest in Q2 2023 (a decline of 74.5%).
  • Business Quant data shows CLDX's Change in Accured Expenses at -$287,000 (Q1 2026), $4.6 million (Q4 2025) and $13.06 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Celldex Therapeutics 2.48 Bn 2.48 Bn - 10.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.14 Mn
Mar 31, 2026 -287,000.00
Dec 31, 2025 4.60 Mn
Sep 30, 2025 13.06 Mn
Jun 30, 2025 2.09 Mn
Mar 31, 2025 -8.72 Mn
Dec 31, 2024 7.99 Mn
Sep 30, 2024 6.71 Mn
Jun 30, 2024 1.71 Mn
Mar 31, 2024 -4.78 Mn
Dec 31, 2023 3.88 Mn
Sep 30, 2023 8.48 Mn
Jun 30, 2023 478,000.00
Mar 31, 2023 -3.45 Mn
Dec 31, 2022 2.40 Mn
Sep 30, 2022 1.58 Mn
Jun 30, 2022 1.88 Mn
Mar 31, 2022 -2.74 Mn
Dec 31, 2021 1.90 Mn
Sep 30, 2021 2.51 Mn
API Access

Celldex Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CLDX&period=max&api_key=YOUR_API_KEY